Introducing enableCV, a new era of enabling and advancing innovation and partnership in cardiovascular surgery.

enableCV is a wholly-owned subsidiary of Edwards Lifesciences. The mission of this highly focused organization is to bring continued innovation that enhances cardiovascular surgical procedures and techniques. enableCV’s product portfolio consists of devices that enable minimally invasive surgical approaches, as well as cannulae, all of which are used and respected by surgeons worldwide.

Lead transformative and enabling innovation in Cardiac Surgery

Enable a broad spectrum of cardiovascular surgeries and advance minimally invasive surgical approaches.

The lntraClude intra-aortic occlusion device enables minimally-invasive surgical cardiac procedures and is indicated for use in patients undergoing cardiopulmonary bypass.

Important Safety Information

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

enableCV, Inc. is a wholly-owned subsidiary of Edwards Lifesciences and distributor of the Edwards products referred to herein. All devices referred to herein are manufactured by Edwards Lifesciences, One Edwards Way, Irvine CA 92614 USA.